Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rao

Showing results (551-560 of 558) with videos related to

Pageof 56
Sort By:
You have reached the last page of results.This site can display upto 558 results.
Stem Cell Research|May 7, 2018
Establishment of a human embryonic stem cell line with homozygous TP53 R248W mutant by TALEN mediated gene editingAn Xu, Ruoji Zhou, Jian Tu, et al.
Human Gene Therapy|November 13, 2009
piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignanciesPallavi V Raja Manuri, Matthew H Wilson, Sourindra N Maiti, et al.
International Journal of Immunopathology and Pharmacology|January 10, 2013
Ethyl pyruvate administration suppresses growth and invasion of gallbladder cancer cells via downregulation of HMGB1-RAGE axisM-L Li, X-F Wang, Z-J Tan, et al.
Oncogene|June 22, 2010
Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastomaX Shang, S A Vasudevan, Y Yu, et al.
Neuro-Oncology|June 1, 2010
A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivoLitian Yu, Patricia A Baxter, Horatiu Voicu, et al.
The Journal of Pathology|October 15, 2013
Amplification and over-expression of MAP3K3 gene in human breast cancer promotes formation and survival of breast cancer cellsYihui Fan, Ningling Ge, Xiaosong Wang, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|January 7, 2021
[Surgical treatment of primary liver cancer:a report of 10 966 cases]Y X Xia, F Zhang, X C Li, et al.
Leukemia|August 27, 2015
Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL ConsortiumL Deng, Z Y Xu-Monette, S Loghavi, et al.
Pageof 56

Showing results (551-560 of 558) with videos related to

Sort By:
Pageof 56
You have reached the last page of results.This site can display upto 558 results.
Stem Cell Research|May 7, 2018
Establishment of a human embryonic stem cell line with homozygous TP53 R248W mutant by TALEN mediated gene editingAn Xu, Ruoji Zhou, Jian Tu, et al.
Human Gene Therapy|November 13, 2009
piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignanciesPallavi V Raja Manuri, Matthew H Wilson, Sourindra N Maiti, et al.
International Journal of Immunopathology and Pharmacology|January 10, 2013
Ethyl pyruvate administration suppresses growth and invasion of gallbladder cancer cells via downregulation of HMGB1-RAGE axisM-L Li, X-F Wang, Z-J Tan, et al.
Oncogene|June 22, 2010
Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastomaX Shang, S A Vasudevan, Y Yu, et al.
Neuro-Oncology|June 1, 2010
A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivoLitian Yu, Patricia A Baxter, Horatiu Voicu, et al.
The Journal of Pathology|October 15, 2013
Amplification and over-expression of MAP3K3 gene in human breast cancer promotes formation and survival of breast cancer cellsYihui Fan, Ningling Ge, Xiaosong Wang, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|January 7, 2021
[Surgical treatment of primary liver cancer:a report of 10 966 cases]Y X Xia, F Zhang, X C Li, et al.
Leukemia|August 27, 2015
Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL ConsortiumL Deng, Z Y Xu-Monette, S Loghavi, et al.
Pageof 56